Human TRIM5α and its Role in Restricting HIV-1 and HIV-2 Infections
Author Information
Author(s): Patrick Kaumanns, Isabel Hagmann, Matthias Dittmar
Primary Institution: Department of Virology, University of Heidelberg
Hypothesis
How does human TRIM5α restrict different subtypes of HIV-1 and variants of HIV-2?
Conclusion
Human TRIM5α can significantly restrict HIV-1 infection and has a variable effect on HIV-2, depending on the viral subtype and entry route.
Supporting Evidence
- TRIM5α restricts HIV-1 infection by up to 100 fold in some species.
- Human TRIM5α shows limited activity against HIV-1 but efficiently restricts N-tropic strains of murine leukemia virus.
- HIV-2 is restricted by both TRIM5α and another factor called Lv2.
- Different HIV-1 subtypes show variable restriction levels by TRIM5α.
Takeaway
This study shows that a protein called TRIM5α helps protect human cells from certain types of HIV, but it works differently depending on the virus.
Methodology
The study used human cell lines overexpressing TRIM5α to test their ability to restrict HIV-1 and HIV-2 infections through various experimental challenges.
Limitations
The study does not identify the endogenous levels of the restriction factor Lv2, which may influence the results.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website